Cerebras (CBRS) Stock Dips Despite Nordic Expansion and Ark Invest’s $17M Bet

Key Takeaways

• Shares of Cerebras declined 3.6% to $177.50 on Tuesday following the announcement of a significant AI data center partnership in Finland
• The new Mikkeli facility will ultimately deliver 165 MW of IT capacity, with initial 50 MW construction phase already in progress
• Cathie Wood’s Ark Invest accumulated approximately $17 million worth of CBRS shares on Aug. 25, signaling confidence in AI inference market
• Second quarter revenue reached $180.1 million, reflecting 74% growth year-over-year, while cloud segment soared 287% YOY
• Analyst consensus stands at “Strong Buy” with a mean price target of $283.91, suggesting potential upside of approximately 59%

Shares of Cerebras Systems (CBRS) retreated 3.6% to close at $177.50 on Tuesday, despite unveiling a substantial data center collaboration in Finland. The stock has tumbled more than 42% over the trailing twelve months and currently trades over 15% beneath its 20-day moving average.

Cerebras Systems Inc., CBRS

The Finnish arrangement involves Compute Nordic Finland and encompasses a new artificial intelligence data center located in Mikkeli. The installation will be completed in stages, ultimately achieving 165 MW of contracted IT capacity. Development of the initial 50 MW segment has commenced.

Individual service orders within the partnership include seven-year terms, providing Cerebras with extended infrastructure access for its AI computing platform. The initiative is anticipated to generate employment opportunities throughout the Mikkeli area.

The share price decline amid favorable developments isn’t particularly unusual. Broader market indices weakened, with the Nasdaq (QQQ) falling 1.5% and the S&P 500 declining 0.76%. AI infrastructure stocks typically correlate with overall growth market sentiment.

From a technical perspective, CBRS is positioned beneath both its 20-day SMA of $212.57 and its 50-day SMA of $203.90. The MACD indicator sits below its signal line accompanied by a negative histogram, suggesting diminishing buying momentum. Critical support exists at $173.50, just above the 52-week low of $160.81.

Ark Invest Increases Position

Despite the price decline, Ark Invest actively accumulated shares. On Aug. 25, Ark acquired 93,290 CBRS shares distributed across several ETFs, valued at approximately $17.2 million. This follows previous purchases completed earlier during August.

Wood’s investment rationale focuses on Cerebras’ capabilities in AI inference. The firm’s CS-4 system reportedly delivers up to 30 times faster inference performance compared to GPU-based systems. Cerebras is additionally collaborating with AMD on a disaggregated inference architecture that provides up to five times greater throughput per watt in specific configurations.

The firm maintains strategic relationships with OpenAI, AWS, and AMD, while expanding an inference cloud operation alongside its hardware revenue streams.

Impressive Growth, Elevated Multiple

Cerebras disclosed Q2 revenue of $180.1 million, representing 74% year-over-year expansion. Core revenue achieved $209.9 million, climbing 103% YOY. Cloud and services revenue exploded 287% YOY to $127.7 million, while core gross margin expanded to 41%.

Leadership elevated full-year fiscal 2026 core revenue projections to a range of $880 million to $890 million. Third quarter core revenue guidance was established at $214 million to $216 million.

The firm concluded Q2 holding $8.6 billion in cash, restricted cash, and short-term investments, alongside $25.4 billion in remaining performance obligations. Additionally, more than 600 MW of data center capacity is operational or contractually secured.

The valuation remains elevated. With a market capitalization approaching $42.5 billion against annual revenue of approximately $510 million, the price-to-sales multiple stands at 60 times. The company continues reporting GAAP losses.

Wall Street maintains an optimistic outlook notwithstanding the premium valuation. Among 11 covering analysts, eight assign “Strong Buy” ratings, one “Moderate Buy,” and two “Hold.”

The consensus price target reaches $283.91. UBS maintains a $330 objective, Morgan Stanley elevated its target to $279, and Wedbush increased its forecast to $290.

The upcoming earnings release is projected for November 19, 2026, with Street expectations calling for revenue of $214.90 million and an EPS loss of 14 cents.